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GCTA: A Tool for Genome-wide Complex Trait Analysis
Jian Yang,1,* S. Hong Lee,1 Michael E. Goddard,2,3 and Peter M. Visscher1
For most human complex diseases and traits, SNPs identified by genome-wide association studies (GWAS) explain only a small fraction
of the heritability. Here we report a user-friendly software tool called genome-wide complex trait analysis (GCTA), which was developed
based on a method we recently developed to address the ‘‘missing heritability’’ problem. GCTA estimates the variance explained by all
the SNPs on a chromosome or on the whole genome for a complex trait rather than testing the association of any particular SNP to the
trait. We introduce GCTA’s five main functions: data management, estimation of the genetic relationships from SNPs, mixed linear
model analysis of variance explained by the SNPs, estimation of the linkage disequilibrium structure, and GWAS simulation. We focus
on the function of estimating the variance explained by all the SNPs on the X chromosome and testing the hypotheses of dosage
compensation. The GCTA software is a versatile tool to estimate and partition complex trait variation with large GWAS data sets.Despite the great success of genome-wide association
studies (GWAS), which have identified hundreds of SNPs
conferring the genetic variation of human complex
diseases and traits,1 the genetic architecture of human
complex traits still remains largely unexplained. For most
traits, the associated SNPs from GWAS only explain a small
fraction of the heritability.2,3 There has not been any
consensus on the explanation of the ‘‘missing heritability.’’
Possible explanations include a large number of common
variants with small effects, rare variants with large effects,
and DNA structural variation.2,4 We recently proposed a
method of estimating the total amount of phenotypic
variance captured by all SNPs on the current generation
of commercial genotyping arrays and estimated that
~45% of the phenotypic variance for human height can
be explained by all common SNPs.5 Thus, most of the
heritability for height is hiding rather than missing
because of many SNPs with small effects.5,6 In contrast to
single-SNP association analysis, the basic concept behind
our method is to fit the effects of all the SNPs as random
effects by a mixed linear model (MLM),
y ¼ XbþWuþ 3 with varðyÞ ¼ V ¼WW0s2u þ Is23 ;
(Equation 1)
where y is an n 3 1 vector of phenotypes with n being the
sample size, b is a vector of fixed effects such as sex, age,
and/or one or more eigenvectors from principal compo-
nent analysis (PCA), u is a vector of SNP effects with
u  Nð0; Is2uÞ, I is an n3 n identity matrix, and 3 is a vector
of residual effects with 3  Nð0; Is23 Þ. W is a standardized
genotype matrix with the ijth element wij ¼ ðxij  2piÞ=ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2pið1 piÞ
p
, where xij is the number of copies of the refer-
ence allele for the ith SNP of the jth individual and pi is the
frequency of the reference allele. If we define A ¼WW0=N
and define s2g as the variance explained by all the SNPs,
i.e., s2g ¼ Ns2u, with N being the number of SNPs, then
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where g is an n3 1 vector of the total genetic effects of the
individuals with g  Nð0;As2gÞ, and A is interpreted as the
genetic relationship matrix (GRM) between individuals.
We can therefore estimate s2g by the restricted maximum
likelihood (REML) approach,10 relying on the GRM esti-
mated from all the SNPs. Here we report a versatile tool
called genome-wide complex trait analysis (GCTA), which
implements the method of estimating variance explained
by all SNPs, and extend themethod to partition the genetic
variance onto each of the chromosomes and also to esti-
mate the variance explained by the X chromosome and
test for dosage compensation in females. We developed
GCTA in five function domains: datamanagement, estima-
tion of the GRM from a set of SNPs, estimation of the vari-
ance explained by all the SNPs on a single chromosome or
the whole genome, estimation of linkage disequilibrium
(LD) structure, and simulation.Estimation of the Genetic Relationship
from Genome-wide SNPs
One of the core functions of GCTA is to estimate the
genetic relationships between individuals from the SNPs.
From the definition above, the genetic relationship
between individuals j and k can be estimated by the
following equation:
Ajk ¼ 1
N
XN
i¼1

xij  2pi

xik  2pi

2pi

1 pi
 : (Equation 3)
We provide a function to iteratively exclude one indi-
vidual of a pair whose relationship is greater than a speci-
fied cutoff value, e.g., 0.025, while retaining the maximum
number of individuals in the data. For data collected from
family or twin studies, we recommend that users estimate
the genetic relationships with all of the autosomal SNPs
and then use this option to exclude close relatives. Thecal Research, 300 Herston Road, Brisbane, Queensland 4006, Australia;
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reason for exclusion is that the objective of the analysis is
to estimate genetic variation captured by all the SNPs, just
as GWAS does for single SNPs. Including close relatives,
such as parent-offspring pairs and siblings, would result
in the estimate of genetic variance being driven by the
phenotypic correlations for these pairs (just as in pedigree
analysis), and this estimate could be a biased estimate of
total genetic variance, for example because of common
environmental effects. Even if the estimate is not biased,
its interpretation is different from the estimate from ‘‘unre-
lated’’ individuals: a pedigree-based estimator captures the
contribution from all causal variants (across the entire
allele frequency spectrum), whereas our method captures
the contribution from causal variants that are in LD with
the genotyped SNPs.
As a by-product, we provide a function in GCTA to
calculate the eigenvectors of the GRM, which is asymptot-
ically equivalent to those from the PCA implemented in
EIGENSTRAT11 because the GRM (Ajk) defined in GCTA is
approximately half of the covariance matrix (Jjk) used in
EIGENSTRAT. The only purpose of developing this func-
tion is to calculate eigenvectors and then include them
in the model as covariates to capture variance due to
population structure. More sophisticated analyses of the
population structure can be found in programs such as
EIGENSTRAT11 and STRUCTURE.12
Estimation of the Variance Explained by Genome-
wide SNPs by REML
The GRM estimated from the SNPs can be fitted subse-
quently in an MLM to estimate the variance explained
by these SNPs via the REML method.10 Previously, we
included only one genetic factor in the model. Here we
extend the model in a general form as
y ¼ Xbþ
Xr
i¼1
gi þ 3;
where gi is a vector of random genetic effects, which could
be the total genetic effects for the whole genome or for
a single chromosome. In this model, the phenotypic vari-
ance (s2P) is partitioned into the variance explained by
each of the genetic factors and the residual variance,
V ¼
Xr
i¼1
Ais
2
i þ Is23 ;
where s2i is the variance of the i
th genetic factor with its
corresponding GRM, Ai.
In GCTA, we provide flexible options to specify different
genetic models. For example:
(1) To estimate the variance explained by all autosomal
SNPs, we can specify the model as y ¼ Xb þ g þ 3 with
V ¼ Ags2g þ Is23 , where g is an n3 1 vector of the aggregate
effects of all the autosomal SNPs for all of the individuals
and Ag is the GRM estimated from these SNPs. This model
is the same as Equation 2.
(2) To estimate the variance of genotype-environment
interaction effects (s2ge), we can specify the model asThe Ay ¼ Xb þ g þ ge þ 3 with V ¼ Ags2g þAges2ge þ Is23 , where
ge is a vector of genotype-environment interaction effects
for all of the individuals withAge¼Ag for the pairs of indi-
viduals in the same environment and with Age ¼ 0 for the
pairs of individuals in different environments.
(3) To partition genetic variance onto each of the
22 autosomes, we can specify the model as y ¼ XbþP22
i¼1gi þ 3 with V ¼
P22
i¼1Ais
2
i þ Is23 , where gi is a vector
of genetic effects attributed to the ith chromosome and
Ai is the GRM estimated from the SNPs on the i
th chromo-
some.
GCTA implements the REML method via the average
information (AI) algorithm.13 In the REML iteration pro-
cess, the estimates of variance components from the tth
iteration are updated by qðtþ1Þ ¼ qðtÞ þ ðAIðtÞÞ1vL=vqjqðtÞ,
where q is a vector of variance components (s21, ., s
2
r
and s23 ); L is the log likelihood function of the MLM
(ignoring the constant), L ¼ 1=2ðlogjVj þ logjX0V1Xjþ
y0PyÞ with P ¼ V1 V1XðX0V1XÞ1X0V1; AI is the
average of the observed and expected information
matrices,
AI¼1=2
y0PA1PA1Py / y0PA1PArPy y0PA1PPy
« « « «
y0PArPA1Py / y0PArPArPy y0PArPPy
y0PPA1Py / y0PPArPy y0PPPy
2
664
3
775;
and vL=vq is a vector of first derivatives of the log likeli-
hood function with respect to each variance component,
vL=vq ¼ 1=2
trðPA1Þ  y0PA1Py
«
trðPArÞ  y0PArPy
trðPÞ  y0PPy
2
664
3
775.13 At the beginning
of the iterationprocess, all of the components are initialized
by an arbitrary value, i.e., s
2ð0Þ
i ¼ s2P=ðr þ 1Þ, which is sub-
sequently updated by the expectation maximization (EM)
algorithm, s
2ð1Þ
i ¼ ½s4ð0Þi y0PAiPyþ trðs2ð0Þi I s4ð0Þi PAiÞ=n.
The EM algorithm is used as an initial step to determine
the direction of the iteration updates because it is robust
to poor starting values. After one EM iteration, GCTA
switches to the AI algorithm for the remaining iterations
until the iteration converges with the criteria of L(t þ 1) –
L(t)<104,whereL(t) is the log likelihoodof the tth iteration.
In the iteration process, any component that escapes from
the parameter space (i.e., its estimate is negative) will be
set to 106 3 s2P. If a component keeps escaping from the
parameter space, it will be constrained at 106 3 s2P.
From the REML analysis, GCTA has an option to provide
the best linear unbiased prediction (BLUP) of the total
genetic effect for all individuals. BLUP is widely used by
plant and animal breeders to quantify the breeding value
of individuals in artificial selection programs14 and also
by evolutionary geneticists.15 Consider Equations 1 and
2, i.e., y¼XbþWuþ 3 and y¼Xbþ gþ 3. Because these
two models are mathematically equivalent,7–9 the BLUP of
g can be transformed to the BLUP of u by bu ¼W0A1bg=N.
Here the estimate of ui corresponds to the coefficient
wij, which is then rescaled for the original xij bymerican Journal of Human Genetics 88, 76–82, January 7, 2011 77
bui ¼ bui= ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ2pið1 piÞp . We could obtain the BLUP of SNP
effects in a discovery set by GCTA and predict genetic
values of the individuals in a validation set (bgnew ¼
Wnew bu). For example, GCTA could be used to predict
SNP effects in a discovery set, and the SNP effects could
be used in PLINK to predict whole-genome profiles via
the scoring approach in a validation set. If the predictions
are unbiased, then the regression slope of the observed
phenotypes on the predicted genetic values is 1.14 In that
case, the genetic value calculated based on the BLUP of
SNP effects is an unbiased predictor of the true genetic
value in the validation set (gnew), in the sense that
EðgnewjbgnewÞ ¼ bgnew.16,17 Prediction analyses of human
complex traits have demonstrated that many SNPs that
do not pass the genome-wide significance level have
substantial contribution to the prediction.18,19 This option
is therefore useful for the whole-genome prediction anal-
ysis with all of the SNPs, irrespective of their association
p values.Estimation of the Variance Explained by the SNPs
on the X Chromosome
The method of estimating the genetic relationship from
the X chromosome is different to that for the autosomal
SNPs, because males have only one X chromosome. We
modified Equation 3 for the X chromosome as:
AMjk ¼
XN
i¼1

xMij  pi

xMik  pi

pi

1 pi
 for a male-male pair;
AFjk ¼
XN
i¼1

xFij  2pi

xFik  2pi

2pi

1 pi
 for a female-female pair; and
AMFjk ¼
XN
i¼1

xMij  pi

xFik  2pi

ﬃﬃﬃ
2
p
pi

1 pi
 for a male-female pair;
where xMij and x
F
ij are the number of copies of the reference
allele for an X chromosome SNP for a male and a female,
respectively.
Assuming the male-female genetic correlation to be 1,
the X-linked phenotypic covariance between a pair of indi-
viduals is:20
covX

yMj ; y
M
k

¼ E

AMjk

s2XðMÞ for a male-male pair;
covX

yFj ; y
F
k

¼ E

AFjk

s2XðFÞ for a female-female pair; and
covX

yMj ; y
F
k

¼ E

AMFjk

sXðMÞsXðFÞ for a male-female pair;
where s2XðMÞ and s
2
XðFÞ are the genetic variance attributed to
the X chromosome for males and females, respectively.
The relative values of s2XðMÞ and s
2
XðFÞ depend on the
assumption made regarding dosage compensation for X78 The American Journal of Human Genetics 88, 76–82, January 7, 20chromosome genes. There are two alleles per locus in
females, but only one in males. If we assume that each
allele has a similar effect on the trait (i.e., no dosage com-
pensation), the genetic variance on the X chromosome for
females is twice that for males: i.e., s2X ¼ s2XðFÞ ¼ 2s2XðMÞ.
Thus,
covX

yMj ; y
M
k

¼ 1=2E

AMjk

s2X for a male-male pair;
covX

yFj ; y
F
k

¼ E

AFjk

s2X for a female-female pair; and
covX

yMj ; y
F
k

¼ 1=
ﬃﬃﬃ
2
p
E

AMFjk

s2X for a male-female pair:
This can be implemented by redefining GRM for the X
chromosome as ANDX ¼ 1=2AX for male-male pairs,
ANDX ¼ AX for female-female pairs, and ANDX ¼ 1=
ﬃﬃﬃ
2
p
AX
for male-female pairs. If we assume that each allele in
females has only half the effect of an allele in males (i.e.,
full dosage compensation), the X-linked genetic variance
for females is half that for males: i.e., s2X ¼ s2XðFÞ ¼
1=2s2XðMÞ. Thus,
covX

yMj ; y
M
k

¼ 2E

AMjk

s2X for a male-male pair;
covX

yFj ; y
F
k

¼ E

AFjk

s2X for a female-female pair; and
covX

yMj ; y
F
k

¼
ﬃﬃﬃ
2
p
E

AMFjk

s2X for a male-female pair:
Therefore, the raw AX matrix should be parameterized as
AFDX ¼ 2AX for male-male pairs, AFDX ¼ AX for female-
female pairs, and ANDX ¼
ﬃﬃﬃ
2
p
AX for male-female pairs.
The third possibility is to assume equal genetic variance
on the X chromosome for males and females, i.e., s2X ¼
s2XðFÞ ¼ s2XðMÞ, in which case the AX matrix is not redefined
at all.
We can estimate s2X by fitting the model
y ¼ Xbþ gX þ g þ 3, where gX is a vector of genetic
effects attributable to the X chromosome, with
varðgXÞ ¼ ANDX s2X assuming no dosage compensation,
varðgXÞ ¼ AFDX s2X assuming full dosage compensation,
and varðgXÞ ¼ AXs2X assuming equal X-linked genetic vari-
ance for males and females. Test of dosage compensation
can be achieved by comparing the likelihoods of model
fitting under the three assumptions.Estimation of the Variance Explained
by Genome-wide SNPs for a Case-Control Study
The methodology described above is also applicable for
case-control data, for which the estimate of variance ex-
plained by the SNPs corresponds to variation on the
observed 0–1 scale. Under the assumption of a threshold-
liability model for a disease, i.e., disease liability on the
underlying scale follows standard normal distribution,21
the estimate of variance explained by the SNPs on the11
observed 0–1 scale can be transformed to that on the unob-
served continuous liability scale by a linear transforma-
tion.22 The relationship between additive genetic variance
on the observed 0–1 and unobserved liability scales was
proposed more than a half century ago,23,24 and we
recently extended this transformation to account for ascer-
tainment bias in a case-control study, i.e., a much higher
proportion of cases in the sample than in the general pop-
ulation (unpublished data). We provide options in GCTA
to analyze a binary trait and to transform the estimate on
the 0–1 scale to that on the liability scale with an adjust-
ment for ascertainment bias. There is an important caveat
in applying the methods described herein to case-control
data. Any batch, plate, or other technical artifact that
causes allele frequencies between case and control on
average to be more different than that under the null
hypothesis stating that the samples come from the same
population will contribute to the estimation of spurious
genetic variation, because cases will appear to be more
related to other cases than to controls. Therefore, stringent
quality control is essential when applying GCTA to case-
control data. Quantitative traits are less likely to suffer
from technical genotyping artifacts because they will
generally not lead to spurious association between contin-
uous phenotypes and genotypes.Estimation of the Inbreeding Coefficient
from Genome-wide SNPs
Apart from estimating the genetic relatedness between
individuals, GCTA also has a function to estimate the
inbreeding coefficient (F) from SNP data, i.e., the relation-
ship between haplotypes within an individual. Two esti-
mates have been used: one based on the variance of addi-
tive genetic values (diagonal of the SNP-derived GRM)
and the other based on SNP homozygosity (implemented
in PLINK).25 Let (1 – pi)
2 þ pi(1 – pi)F, 2pi(1 – pi)(1 – F),
and pi
2 þ pi(1 – pi)F be the frequencies of the three geno-
types of a SNP i and let hi ¼ 2pi(1 – pi). The estimate based
on the variance of additive genotype values is
bF Ii ¼ ½xi  EðxiÞ2=hi  1 ¼ xi  2pi2=hi  1 and var
bF Ii j F

¼ ð1 hiÞ=hi þ 7ð1 2hiÞF=hi  F2;
where xi is the number of copies of the reference allele for
the ith SNP. This is a special case of Equation 3 for a single
SNP when j ¼ k. The estimate based upon excess homozy-
gosity is
bF IIi ¼ ½Oð#homÞ  Eð#homÞ=½1 Eð#homÞ
¼ 1 xið2 xiÞ=hi and var
bF IIi j F

¼ ð1 hiÞ=hi
 ð1 2hiÞF=hi  F2;
where O(# hom) and E(# hom) are the observed and ex-
pected number of homozygous genotypes in the sample,
respectively. Both estimators are unbiased estimates of F
in the sense that EðbF Ii jFÞ ¼ EðbF IIi jFÞ ¼ F, but their samplingThe Avariances are dependent on allele frequency, i.e., varðbF IiÞ ¼
varðbF IIi Þ ¼ (1 – hi) / hi if F ¼ 0. In addition, the covariance
between the two estimators is (3hi – 1) / hi þ (1 – 2hi)F /
hi – F
2, so that the sampling covariance between the esti-
mators is (3hi – 1) / hi and the sampling correlation is
(3hi – 1) / (1 – hi) when F ¼ 0. We proposed an estimator
based upon the correlation between uniting gametes:5
bF IIIi ¼ x2i  1þ 2pixi þ 2p2i 	hi and var
bF IIIi j F

¼ 1þ 2ð1 2hiÞF=hi  F2:
bF IIIi is also an unbiased estimator of F in the sense that
E ðbF IIIi jFÞ ¼ F. If F ¼ 0, varðbF IIIi Þ ¼ 1 regardless of allele
frequency, which is smaller than the sampling variance
of bF Ii and bF IIi , i.e., 1 % (1 – hi) / hi. When 0 < F < 1/3, bF IIIi
also has a smaller variance than bF Ii and bF IIi . In GCTA, we
use 1 þ bF IIIi rather than 1 þ bF Ii to calculate the diagonal
of the GRM. For multiple SNPs, we average the estimates
over all of the SNPs, i.e., bF ¼ 1=NPNi¼1bFi.
Estimating LD Structure
In a standard GWAS, particularly with a large sample size,
the mean (lmean) or median (lmedian) of the test statistics
for single-SNP associations often deviates from its expected
value under the null hypothesis of no association between
any SNP and the phenotype, which is usually interpreted
as the effect due to population stratification and/or cryptic
relatedness.11,26,27 An alternative explanation is that poly-
genic variation causes the observed inflated test statistic.18
To predict the genomic inflation factors, lmean and lmedian,
from polygenic parameters such as the total amount of
variance that is explained by all SNPs, we need to quantify
the LD structure between SNPs and putative causal variants
(unpublished data). GCTA provides a function to search for
all the SNPs in LD with the ‘‘causal variants’’ (mimicked by
a set of SNPs chosen by the user). Given a causal variant, we
use simple regression to test for SNPs in LD with the causal
variant within dMb distance in either direction. PLINK has
an option (‘‘show targets’’) to select SNPs in LDwith a set of
target SNPs with LD r2 larger than a user-specified cutoff
value. This function is very useful to distinguish indepen-
dent association signals but less suited to predict lmean and
lmedian, because the test statistics of the SNPs in modest LD
with causal variants (SNPs at Mb distance with low r2) will
also be inflated to a certain extent, and these test statistics
will contribute to the genomic inflation factors.
GWAS Simulation
Weprovided a function to simulateGWASdatabasedon the
observed genotype data. For a quantitative trait, the pheno-
types are simulated by the simple additive genetic model
y¼Wuþ 3, where the notation is the same as above. Given
a set of SNPs assigned as causal variants, the effects of the
causal variants are generated from a standard normal distri-
bution, and the residual effects are generated from anormal
distribution with mean of 0 and variance of s2g ð1=h2  1Þ,merican Journal of Human Genetics 88, 76–82, January 7, 2011 79
where s2g is the empirical variance ofWu and h
2 is the user
specified heritability. For a case-control study, assuming
a threshold-liability model, disease liabilities are simulated
in the sameway as that for the phenotypes of a quantitative
trait. Any individual with disease liability exceeding
a certain threshold T is assigned to be a case and a control
otherwise, where T is the threshold of normal distribution
truncating the proportion of K (disease prevalence). The
only purpose of this function is to do a simple simulation
based on the observed genotype data. More complicated
simulation can be performed with programs such as ms,28
GENOME,29 FREGENE,30 and HAPGEN.31Data Management
We chose the PLINK25 compact binary file format (*.bed,
*.bim, and *.fam) as the input data format forGCTAbecause
of its popularity in the genetics community and its effi-
ciency of data storage. For the imputed dosage data, we
use the output files of the imputation program MACH32
(*.mldose.gz and *.mlinfo.gz) as the inputs for GCTA. For
the convenience of analysis, we provide options to extract
a subset of individuals and/or SNPs and to filter SNPs based
on certain criteria, such as chromosome position, minor
allele frequency (MAF), and imputation R2 (for the imputed
data). However, we donot provide functions for a thorough
quality control (QC) of the data, such as Hardy-Weinberg
equilibrium test and missingness, because these functions
have been well developed in many other genetic analysis
packages, e.g., PLINK, GenABEL,33 and SNPTEST.34 We
assume that the data have been cleaned by a standard QC
process before entering into GCTA.Estimating Total Heritability
The method implemented in GCTA is to estimate the vari-
ance explained by chromosome- or genome-wide SNPs
rather than the trait heritability. Estimating the heritability
(i.e., variance explained by all the causal variants), however,
relies on the genetic relationship at causal variants that is
predicted with error by the genetic relationship derived
from the SNPs as a result of imperfect tagging. We have
previously established that the prediction error is c þ 1 / N,
with c depending on the distribution of the MAF of causal
variants.We therefore developed amethod based on simple
regression to correct for the prediction error by
Ajk ¼
8<
:
1þ bAjj  1; j ¼ k
bAjk; jsk;
where b ¼ 1 ðc þ 1=NÞ=varðAjkÞ. The estimate of variance
explained by all of the SNPs after such adjustment is an
unbiased estimate of heritability only if the assumption
about the MAF distribution of causal variants is correct.Efficiency of GCTA Computing Algorithm
GCTA implements the REML method based on the vari-
ance-covariance matrix V and the projection matrix P.80 The American Journal of Human Genetics 88, 76–82, January 7, 20In some of the mixed model analysis packages, such as
ASREML,35 to avoid the inversion of the n 3 n V matrix,
people usually use Gaussian elimination of the mixed
model equations (MME) to obtain the AI matrix based
on sparse matrix techniques. The SNP-derived GRM
matrix, however, is typically dense, so the sparse matrix
technique will bring an extra cost of memory and CPU
time. Moreover, the dimension of MME depends on the
number of random effects in the model, whereas the V
matrix does not. For example, when fitting the 22 chromo-
somes simultaneously in the model, the dimension of
MME is 22n 3 22n (ignoring the fixed effects), whereas
the dimension of V matrix is still n 3 n. We compared
the computational efficiency of GCTA and ASREML.
When the sample size is small, e.g., n < 3000, both
GCTA and ASREML take a few minutes to run. When the
sample size is large, e.g., n> 10,000, especially when fitting
multiple GRMs, it takes days for ASREML to finish the anal-
ysis, whereas GCTA needs only a few hours.
System Requirements
We have released executable versions of GCTA for the
three major operating systems: MS Windows, Linux/
Unix, and Mac OS. We have also released the source codes
so that users can compile them for some specific platforms.
GCTA requires a large amount of memory when calcu-
lating the GRM or performing an REML analysis with
multiple genetic components. For example, it requires
~4.8 GB memory to calculate the GRM for a data set with
3925 individuals genotyped by 294,831 SNPs, and it takes
~4 CPU hours (AMD Opteron 2.8 GHz) to finish the
computation. We therefore recommend using the 64-bit
version of GCTA for large memory support.
Nonadditive Genetic Variance
The analysis approach we have adapted is a logical exten-
sion of estimation methods based on pedigrees. It allows
estimation of additive genetic variation that is captured
by SNP arrays and is therefore informative with respect
to the genetic architecture of complex traits. The estimate
of variance captured by all of the SNPs obtained in GCTA is
directly comparable to the heritability estimated from
pedigree analysis in family and twin studies, as well as
the variance explained by GWAS hits, so that missing
and hiding heritability can be quantified.5 Other sources
of genetic variations such as dominance, gene-gene inter-
action, and gene-environment interaction are also impor-
tant for complex trait variation but are less relevant to
the ‘‘missing heritability’’ problem if the total heritability
refers to the narrow-sense heritability, i.e., the proportion
of phenotypic variance due to additive genetic variance.
The current version of GCTA only provides functions to
estimate and partition the variances of additive and
additive-environment interaction effects. It is technically
feasible to extend the analysis to include dominance
and/or gene-gene interaction effects in the future.
However, the power to detect the high-order genetic11
variation will be limited, i.e., the sampling variance of esti-
mated variance components will be very large. Future
developments will also include options to do multivariate
analyses, to read genotype or imputed probability data in
different formats, and to implement other applications of
whole-genome or chromosome segment approaches.
In summary, we have developed a versatile tool to esti-
mate genetic relationships from genome-wide SNPs that
can subsequently be used to estimate variance explained
by SNPs via a mixed model approach. We provide flexible
options to specify different genetic models to partition
genetic variance onto each of the chromosomes. We devel-
oped methods to estimate genetic relationships from the
SNPs on the X chromosome and to test the hypotheses
of dosage compensation. GCTA is not limited to the anal-
ysis of data on human complex traits, but in this report we
only use examples and specifications (e.g., the number of
autosomes) for humans.Acknowledgments
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